Marc L Schermerhorn, MD
Division Chief
Vascular Surgery
Contact Information
| Office: | DE-0207 |
| Phone: | 617-632-9971 |
| Fax: | 617-632-7977 |
| Email: | mscherme@bidmc.harvard.edu |
| Address: | 330 Brookline Ave; DE-0207
Boston, MA 02215 |
Advanced Degree And Training
| Year | Institution | Area or Rank |
| 1991 | Georgetown | Medicine |
| 1998 | BIDMC | General Surgery |
| 2000 | Dartmouth Hitchcock Medical Center | Vascular Surgery |
Major Research Theme
| My research is focused on comparing outcomes of standard open vascular surgery with minimally invasive endovascular surgery. I use large databases (Medicare, Nationwide Inpatient Sample, NSQIP, etc) as well as our own local registry to compare outcomes to help determine which therapy is appropriate for specific patient populations. |
Publications
External Recognition
| Major Committee Assignments: Dartmouth Hitchcock Medical Center, Lebanon, NH 2001-2004 Radiation Safety Committee, Beth Israel Deaconess Medical Center, Boston, MA 2004- Interventional Procedures Committee 2004- MD Oversight Workgroup 2005- Simulation Training Steering Committee 2005- Surgical Database Development Committee 2005- Carotid Stenting Committee Harvard Medical School, Boston, MA 2004- Clinical Events Committee, Harvard Clinical Research Institute New England Society for Vascular Surgery 2004- Issues Committee 2007- Post Graduate Course Director Executive Committee Society for Vascular Surgery 2005- Outcomes Committee American Heart Association 2006-2007 Annual Meeting Program Committee PRESENTATIONS: A. “Does Endovascular Repair of AAA Change the Threshold for Fixing Small Aneurysms?†Presented at the 87th Clinical Congress of the American College of Surgeons, New Orleans, LA, October 11, 2001. B. “Carotid Stenting – Developing a Surgical Programâ€. Presented at the Spring Meeting of the American College of Surgeons, Boston, MA, April 26, 2004. C. “Choosing Carotid Stenting vs. Endarterectomy.†Presented at the Annual Meeting of the New England Society for Vascular Surgery, Whitefield, NH, September 19, 2004. D. “Office Based Evaluation of Peripheral Vascular Disease.†Presented at the Diabetic Foot Management course, Harvard Medical School continuing medical education. Boston, MA, November 21, 2004. E. “Minimally Invasive Therapy for Peripheral Arterial Disease.†Presented at Grand Rounds, Holy Family Hospital. Methuen, MA, January 20, 2005. F. “Indications for Inferior Vena Cava Filters†Current Concepts and Controversies in Vascular and Endovascular Surgery 2005. Boston, MA, May 13, 2005. G. “The Merits of Carotid Stenting†American Stroke Association Professional Symposium, Boston, MA, May 20, 2005. H. “Is Endovascular Therapy Appropriate First Line Treatment of Infrainguinal Occlusive Disease?†Presented at the American College of Surgeons Annual Meeting. San Francisco, CA, October 18, 2005. I. “Complications of Thoracic Endografting†Presented at the Annual Meeting of the Society for Thoracic Surgery. Chicago, IL, February 1, 2006. J. “Should Usual Criteria for Intervention be ‘Downsized’ Considering Reported Risk-reduction with Endovascular Repair?†Presented at the New York Academy of Sciences Tenth Anniversary Symposium “The Abdominal Aortic Aneurysm: Genetics, Pathophysiology, and Molecular Biologyâ€. New York, New York, April 3, 2006. K. “How Can surgeons be Trained to do Carotid Stenting?†Contemporary Practice of Vascular and Endovascular Surgery 2006. Boston, MA, May 11, 2006. L. “Technical Tips for Stenting with Complex Carotid Anatomy†Presented at the Annual Meeting of the Society for Vascular Surgery. Philadelphia, PA, May 31, 2006. M. “Tibial Angioplasty†Presented at the Annual Meeting of the New England Society for Vascular Surgery. Boston, MA, September 23, 2006. N. “Stentgraft Treatment of Combined Aortic Arch and Descending Thoracic Aortic Pathology†Presented at the Annual Meeting of the New England Society for Vascular Surgery. Boston, MA, September 23, 2006. O. “Selecting Patients for Carotid Stenting†Presented at Updates and Advances in Vascular and Endovascular Surgery. Boston, MA, May 10, 2007. P. “Carotid Stenting, Understanding When to Stop and When Not to Start†Presented at the Society for Vascular Surgery annual meeting, postgraduate course. Baltimore, MD, June 6, 2007. Q. “Bypass is Still Preferred for TASC C and D Disease of the SFA – Con. Debate with Dr Joeseph Mills at the Society for Vascular Surgery annual meeting. Baltimore, MD, June 9, 2007. R. “Management of Endoleaks†Presented at the Annual Meeting of the New England Society for Vascular Surgery. Foxwoods, CT, October 5, 2007. S. “Perioperative and 4-year Outcomes of Endovascular and Open AAA Repair in the US Medicare Population†Presented at the Annual Meeting of the New England Society for Vascular Surgery. Foxwoods, CT, October 5, 2007. T. “National Outcomes of Open Decending Thoracic Aneurysm Repairâ€. Presented at the Annual Meeting of the Society for Clinical vascular Surgery. Las Vegas, NV, March 6, 2008 U. “Endovascular versus Open AAA Repair†Beth Israel Deaconess Medical Center, Anesthesia Grand Rounds. Boston, MA, July 2, 2008. V. “EVAR vs Open AAA Repair in US Medicare Patients†Presented at the Annual Meeting of the European society for Vascular Surgery, Nice, France, September 7, 2008. |
Major Collaborative Activities
| I am currently collaborating with Drs Bruce Landon and James O'Malley from the Department of Health Care Policy at Harvard Medical School and with resident researchers supported by the T32 training grant of Dr Frank LoGerfo. |
Investigator's Lab Web Site
| Research Lab URL | None listed |
| Harvard Catalyst Site: | Schermerhorn Harvard Catalyst Web Site |
